NKTR - Nektar Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

NKTR is currently covered by 9 analysts with an average price target of $146.93. This is a potential upside of $99.94 (212.68%) from yesterday's end of day stock price of $46.99.

Nektar Therapeutics's activity chart (see below) currently has 140 price targets and 169 ratings on display. The stock rating distribution of NKTR is 75% BUY and 25% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 44.27% with an average time for these price targets to be met of 227.97 days.

Highest price target for NKTR is $192, Lowest price target is $50, average price target is $146.93.

Most recent stock forecast was given by JULIAN HARRISON from BTIG. First documented stock forecast 27-Jul-2014.

Currently out of the existing stock ratings of NKTR, 18 are a BUY (75%), 6 are a HOLD (25%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 29-Sep-2024

$178

$117.6 (194.70%)

$178

Hold Since 23-Mar-2026

$50

$-10.4 (-17.22%)

$80

9 days ago
(22-Sep-2026)

2/5 (40%)

$-7.66 (-13.28%)

2

Hold Since 20-Aug-2026

$65

$4.6 (7.62%)

1 months 11 days ago
(20-Aug-2026)

6/10 (60%)

$-9.02 (-12.19%)

107

Buy Since 03-Nov-2024

$192

$131.6 (217.88%)

$192

3 months 27 days ago
(04-Jun-2026)

1/4 (25%)

$134.68 (234.96%)

532

Buy Since 16-Mar-2026

$151

$87.35 (137.23%)

$123

5 months 11 days ago
(21-Apr-2026)

0/3 (0%)

$52.84 (53.83%)

Show more analysts

Please expand the browser size to see the chart

What is NKTR (Nektar Therapeutics) average time for price targets to be met?

On average it took 228 days for the stock forecasts to be reached, with an average price target met ratio of 44.27%.

Which analyst most recently updated their price target on NKTR (Nektar Therapeutics)?

Julian Harrison

Which analyst has the most public recommendations on NKTR (Nektar Therapeutics)?

Julian Harrison works at BTIG and has 24 price targets and 17 ratings on NKTR

Which analyst is the currently most bullish on NKTR (Nektar Therapeutics)?

Corey Davis with the highest potential upside of $1739.6

Which analyst is the currently most reserved on NKTR (Nektar Therapeutics)?

Benjamin Burnett with the lowest potential downside of -$15.4
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?